BIRMINGHAM, Ala., Feb. 28, 2025 /PRNewswire/ — IllumiCare is the market leader in “nudging” healthcare providers in their EMR ordering workflow when specific opportunities arise to be more clinically and fiscally efficient. These opportunities stem from IllumiCare’s proprietary and growing library of clinical financial decision support rules and content.
Today the company announces a new way to engage clinicians to reflect on their practice habits and become better stewards of hospital resources (and patient bills).
For years, IllumiCare has given each clinician a personal view of how they compare to their peers. That information has been delivered via a “Variations app” found on its Smart Ribbon platform. Now, IllumiCare is making this information more accessible – each clinician’s opportunities for improvement will be delivered directly to their mobile phone via SMS message.
“Our biggest impact comes when we make a recommendation where and when a specific decision about a specific patient is being made,” said G.T. LaBorde, CEO of IllumiCare. “Supplementing this content with a monthly mobile data push will reinforce a stewardship mindset and highlight opportunities to improve.”
The new mobile solution will launch across multiple US healthcare facilities in Q2 2025. For more information, visit www.illumicare.com.
About IllumiCare
IllumiCare was founded in Birmingham, Ala., and has helped align behavior at 350+ healthcare facilities through its foundational nudge technology. With deep experience in the clinical, financial, and technical aspects of hospital operations, IllumiCare created the Smart Ribbon, which combines actionable clinical and financial intelligence in a transcendent platform. Learn more at www.illumicare.com.
SOURCE IllumiCare
– Phase 1a clinical data in healthy participants presented for both ABI-5366 and ABI-1179, novel…
Atlanta, GA., July 25, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCBQ: RHEP)…
TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”)…
SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”)…
DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”)…
ORLANDO, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="12px" width="12px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="1000px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
